What truly sets us apart is not just that we use regenerative medicine, but how precisely we engineer and guide tissue healing. We do not follow a one-size fits all stem cell approach. Instead we practice guided tissue healing through biologic mapping, where imaging, biomechanics, and tissue specific biology detmermine what regenerative approach is used, where it is placed, and how it is scaffolded. We selecitively deploy, cells extracted from patients, including BMAC, MFat, PRP, and fibrinogen scaffolds based on Tissue diffusibility, mechanical load, and healing capacity.
Our program prioritizes cell quality and regnerative signaling over raw cell counts, and we custom engineer scaffolds even for lean or athletic patients where traditional techniques fail. Our affliates are also among the first in the nation to intregrate regnerative fractional laser technology to enhance tissue receptivity and targeted biologic delivery.
All treatments are executed with elite image guided accuracy using fluroscopy, and ultrasound. This intregration of biologic mapping, guided tissue healing, scaffold engineering, and delivery precision is what truly seperates us from others offering similar treatments
Up to 8 billion MFAT cells and 30–40% higher BMAC output clinics.
Sterile, image-guided regenerative treatments produce better outcomes.
Appointments within 24–48 hours, MRI review within 72 hours.
Bundled pricing, outcome dashboards, RTW tracking, and cost-savings reporting.


This excludes productivity gains, which often exceed direct cost savings.
313MD with the Regenerative Medicine Institute of Michigan delivers a turnkey, data-driven, regenerative-first MSK solution that outperforms traditional care models in: cost, speed, safety, and patient outcomes.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.